![Nordic Nanovector: Updated Results from Phase 1/2 Trial of Betalutin® in Non-Hodgkin Lymphoma to be Presented at ASH Annual Meeting in December | Business Wire Nordic Nanovector: Updated Results from Phase 1/2 Trial of Betalutin® in Non-Hodgkin Lymphoma to be Presented at ASH Annual Meeting in December | Business Wire](https://www.businesswire.com/images/bwlogo_extreme.png)
Nordic Nanovector: Updated Results from Phase 1/2 Trial of Betalutin® in Non-Hodgkin Lymphoma to be Presented at ASH Annual Meeting in December | Business Wire
![Herantis appoints new Chief Financial Officer - Nordic Life Science – the leading Nordic life science news service Herantis appoints new Chief Financial Officer - Nordic Life Science – the leading Nordic life science news service](https://nordiclifescience.org/wp-content/public_html/2020/10/tone-kva%CC%8Ale.jpg)
Herantis appoints new Chief Financial Officer - Nordic Life Science – the leading Nordic life science news service
![Herantis appoints new Chief Financial Officer - Nordic Life Science – the leading Nordic life science news service Herantis appoints new Chief Financial Officer - Nordic Life Science – the leading Nordic life science news service](https://nordiclifescience.org/wp-content/public_html/2016/03/vertical-accelerator-e1456834794156.jpg)